“This discovery may lead to new approaches for the treatment of patients with certain forms of cancer.”

– Dr. Charles Graham, on the potential of nitric oxide to treat cancer

Success Stories

Novari™ IT solutions

In Canada, patients’ wait times and their journeys through the health care continuum could be shorter and more successful because of a web-based waitlist and patient reporting system developed at Kingston General Hospital. Novari Health of Kingston was founded with PARTEQ’s

Levulan® PhotodynamicTherapy for actinic keratosis

More than one million patients across North, South and Central America have been successfully treated with Levulan® Photodynamic Therapy, a non-invasive, topical light-based treatment for actinic keratosis, the red, scaly lesions caused by overexposure to the sun. Based

Nanovate™ electroplated materials

What do aerospace parts, automotive components, and sporting goods have in common? All are being enhanced by nano-materials research pioneered at Queen’s University, where metallurgist Uwe Erb discovered a novel way to manipulate the grain size of nickel using electrodeposition, a widely used, low-cost

Qubit Sytems customized research and instrumentation systems

For nearly 20 years, scientific research and teaching around the world has been enhanced because of Qubit Systems Inc., of Kingston.  The company was founded, with PARTEQ’s assistance, by Queen’s biologist Dr. David Layzell

KINARM™ robotic assessment system

If you are a Canadian Olympic or varsity athlete, you may have been tested for concussion via the KINARM™, the patented robotic system developed at Queen’s for assessing brain injury. The only system of its kind in the world, the KINARM™ is being adopted by scientific researchers

Q'Straint passenger safety solutions

Elite athletes at the Beijing Paralympics are just some of the millions of wheelchair van passengers around the world who have reached their destinations safely, thanks to pioneering research at Queen’s into ‘seatbelts’ for wheelchairs and their

1
2
3
4
5
6

Videos

PARTEQ Blog

Dr. Jeremy Squire
Apr. 15 2014

A few years ago, Jeremy Squire, PhD, and his Queen’s University research team made an important discovery that exposed them to the mysterious world of patenting and commercialization.  Dr. Squire and his team identified a possible cause for the loss of a tumor-suppressor gene that plays a critical role in prostate cancer.   Patients who are missing this gene have been associated with the development of...

Pages